| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.718 | 19.248 | 21.115 | 19.379 | 9.644 | 28.082 | 18.206 | 37.921 | - | - |
| Total Income - EUR | 24.718 | 19.248 | 21.115 | 19.379 | 13.743 | 28.082 | 18.257 | 38.418 | - | - |
| Total Expenses - EUR | 23.034 | 18.559 | 20.370 | 18.289 | 12.985 | 27.228 | 18.051 | 30.633 | - | - |
| Gross Profit/Loss - EUR | 1.684 | 688 | 745 | 1.090 | 758 | 854 | 206 | 7.784 | - | - |
| Net Profit/Loss - EUR | 943 | 113 | 106 | 508 | 468 | 196 | -210 | 7.405 | - | - |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - |
Check the financial reports for the company - Biocons Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 729 | 716 | 4.485 | 4.400 | 4.302 | 4.315 | - | - |
| Current Assets | 3.337 | 10.244 | 10.637 | 7.993 | 20.206 | 27.042 | 43.657 | 41.908 | - | - |
| Inventories | 2.428 | 9.513 | 9.914 | 7.272 | 19.535 | 26.360 | 41.065 | 41.579 | - | - |
| Receivables | 732 | 725 | 713 | 699 | 668 | 658 | 1.591 | 263 | - | - |
| Cash | 177 | 6 | 11 | 21 | 3 | 25 | 1.001 | 66 | - | - |
| Shareholders Funds | -3.350 | -3.203 | -3.043 | -2.478 | -1.962 | -1.729 | -1.901 | 5.498 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 6.688 | 13.447 | 14.408 | 11.187 | 26.653 | 33.170 | 49.860 | 40.725 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4752 - 4752" | |||||||||
| CAEN Financial Year |
4752
|
|||||||||
Comments - Biocons Srl